Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Modulation by Misoprostol
NCT02259309Phase 1Completed
- Sponsor
- Vanderbilt University
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of misoprostol (2 arms), sponsored by Vanderbilt University. Primary endpoints: Misoprostol drug levels at Day 29, Cytokine and chemokine levels at Day 29 and 1 more. Started Nov 2014; status: completed.
02
Drugs
misoprostol
Beyond the preview
Go deeper on NCT02259309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259309.